Gary F. Lewis
About
Gary F. Lewis is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology.
According to data from OpenAlex, Gary F. Lewis has authored 188 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Endocrinology, Diabetes and Metabolism, 69 papers in Surgery and 47 papers in Molecular Biology. Recurrent topics in Gary F. Lewis's work include Diabetes, Cardiovascular Risks, and Lipoproteins (58 papers), Pancreatic function and diabetes (39 papers) and Lipid metabolism and disorders (37 papers). Gary F. Lewis is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (58 papers), Pancreatic function and diabetes (39 papers) and Lipid metabolism and disorders (37 papers). Gary F. Lewis collaborates with scholars based in Canada, United States and United Kingdom. Gary F. Lewis's co-authors include Adria Giacca, Changting Xiao, André C. Carpentier, Khosrow Adeli, Daniel J. Rader, Kristine D. Uffelman, Linda Szeto, George Steiner, Satya Dash and Shirya Rashid and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.
In The Last Decade
Gary F. Lewis
186 papers receiving 11.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gary F. Lewis Canada | 59 | 6.0k | 4.1k | 3.3k | 3.2k | 2.8k | 188 | 12.1k | ||
| Masakazu Haneda Japan | 67 | 5.4k 0.9× | 2.7k 0.7× | 2.3k 0.7× | 4.8k 1.5× | 2.5k 0.9× | 292 | 16.1k | ||
| Wolfgang Patsch Austria | 59 | 4.9k 0.8× | 3.7k 0.9× | 2.8k 0.8× | 3.0k 0.9× | 2.2k 0.8× | 207 | 12.2k | ||
| Daisuke Koya Japan | 75 | 4.1k 0.7× | 2.4k 0.6× | 3.6k 1.1× | 6.6k 2.1× | 3.4k 1.2× | 292 | 18.9k | ||
| Barry J. Goldstein United States | 54 | 3.8k 0.6× | 3.1k 0.7× | 4.0k 1.2× | 6.9k 2.2× | 3.9k 1.4× | 124 | 16.0k | ||
| Josef R. Patsch Austria | 53 | 4.2k 0.7× | 3.1k 0.8× | 2.1k 0.6× | 2.2k 0.7× | 2.0k 0.7× | 195 | 10.0k | ||
| Giorgio Sesti Italy | 67 | 6.9k 1.2× | 3.4k 0.8× | 2.8k 0.9× | 5.6k 1.8× | 2.5k 0.9× | 416 | 15.1k | ||
| Shun Ishibashi Japan | 67 | 4.1k 0.7× | 6.4k 1.5× | 3.0k 0.9× | 6.6k 2.1× | 3.2k 1.1× | 360 | 17.2k | ||
| Josephine M. Forbes Australia | 64 | 5.3k 0.9× | 2.0k 0.5× | 2.5k 0.8× | 4.2k 1.3× | 1.5k 0.5× | 205 | 16.0k | ||
| John D. Brunzell United States | 53 | 5.5k 0.9× | 3.8k 0.9× | 2.1k 0.6× | 2.0k 0.6× | 2.5k 0.9× | 106 | 10.9k | ||
| Fredrik Karpe United Kingdom | 74 | 5.4k 0.9× | 3.7k 0.9× | 6.5k 2.0× | 4.3k 1.4× | 4.5k 1.6× | 285 | 17.6k |
Countries citing papers authored by Gary F. Lewis
Since
Specialization
Citations
This map shows the geographic impact of Gary F. Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary F. Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary F. Lewis more than expected).
Fields of papers citing papers by Gary F. Lewis
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Gary F. Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary F. Lewis. The network helps show where Gary F. Lewis may publish in the future.
Co-authorship network of co-authors of Gary F. Lewis
This figure shows the co-authorship network connecting the top 25 collaborators of Gary F. Lewis. A scholar is included among the top collaborators of Gary F. Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary F. Lewis. Gary F. Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Tian, Lili, Majid Mufaqam Syed‐Abdul, & Gary F. Lewis. (2024). Activation of VEGFR3 and MLC2 are Critical for GLP-2 Enhancement of Chylomicron Transport. SHILAP Revista de lepidopterología. 4(4). 100605–100605.
2.
Ravaut, Mathieu, Maksims Volkovs, Kathy Kornas, et al.. (2021). Predicting adverse outcomes due to diabetes complications with machine learning using administrative health data. npj Digital Medicine. 4(1). 24–24.
3.
MacCallum, Lori, et al.. (2020). Pharmacists report lack of reinforcement and the work environment as the biggest barriers to routine monitoring and follow-up for people with diabetes: A survey of community pharmacists. Research in Social and Administrative Pharmacy. 17(2). 332–343.
4.
Stahel, Priska, et al.. (2020). Role of the Gut in Diabetic Dyslipidemia. Frontiers in Endocrinology. 11. 116–116.
5.
Xiao, Changting, Satya Dash, Priska Stahel, & Gary F. Lewis. (2018). Effects of intranasal insulin on endogenous glucose production in insulin‐resistant men. Diabetes Obesity and Metabolism. 20(7). 1751–1754.
6.
Maraninchi, Marie, Sophie Béliard, B Berthet, et al.. (2017). Impact of bariatric surgery on apolipoprotein C-III levels and lipoprotein distribution in obese human subjects. Journal of clinical lipidology. 11(2). 495–506.e3.
7.
Stahel, Priska, Changting Xiao, & Gary F. Lewis. (2017). Control of intestinal lipoprotein secretion by dietary carbohydrates. Current Opinion in Lipidology. 29(1). 24–29.
8.
Danielle, S., Michael W. Best, Christopher R. Bowie, et al.. (2016). A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder. Journal of Affective Disorders. 210. 57–65.
9.
Dash, Satya, Changting Xiao, Cecilia Morgantini, et al.. (2014). Glucagon-Like Peptide-2 Regulates Release of Chylomicrons From the Intestine. Gastroenterology. 147(6). 1275–1284.e4.
10.
Xiao, Changting, Satya Dash, Cecilia Morgantini, & Gary F. Lewis. (2013). Novel Role of Enteral Monosaccharides in Intestinal Lipoprotein Production in Healthy Humans. Arteriosclerosis Thrombosis and Vascular Biology. 33(5). 1056–1062.
11.
Labonté, Marie‐Ève, David J.A. Jenkins, Gary F. Lewis, et al.. (2013). Adding MUFA to a dietary portfolio of cholesterol-lowering foods reduces apoAI fractional catabolic rate in subjects with dyslipidaemia. British Journal Of Nutrition. 110(3). 426–436.
12.
Xiao, Changting, Satya Dash, & Gary F. Lewis. (2012). Mechanisms of Incretin Effects on Plasma Lipids and Implications for the Cardiovascular System. Cardiovascular & Hematological Agents in Medicinal Chemistry. 10(4). 289–294.
13.
McIntyre, Roger S., Joanna K. Soczynska, Gary F. Lewis, et al.. (2006). Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities. Expert Opinion on Pharmacotherapy. 7(10). 1305–1321.
14.
Xiao, Changting, Adria Giacca, André C. Carpentier, & Gary F. Lewis. (2006). Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans. Diabetologia. 49(6). 1371–1379.
15.
Rashid, Shirya, Bruce W. Patterson, & Gary F. Lewis. (2006). Thematic review series: Patient-Oriented Research. What have we learned about HDL metabolism from kinetics studies in humans?. Journal of Lipid Research. 47(8). 1631–1642.
16.
Leung, Nathalie, Taro Sakaue, André C. Carpentier, et al.. (2004). Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men. Diabetologia. 47(2). 204–213.
17.
Carpentier, André C., Steven D. Mittelman, Richard N. Bergman, Adria Giacca, & Gary F. Lewis. (2000). Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes.. Diabetes. 49(3). 399–408.
18.
Lemieux, Simone, et al.. (1999). Elevated plasma lipids in patients with binge eating disorders are found only in those who are anorexic. International Journal of Eating Disorders. 25(2). 187–193.
19.
Lamarche, Benoı̂t, Kristine D. Uffelman, André C. Carpentier, et al.. (1999). Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. Journal of Clinical Investigation. 103(8). 1191–1199.
20.
Lewis, Gary F., N. O’Meara, P. A. Soltys, et al.. (1990). Postprandial Lipoprotein Metabolism in Normal and Obese Subjects: Comparison after the Vitamin A Fat-Loading Test*. The Journal of Clinical Endocrinology & Metabolism. 71(4). 1041–1050.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Masakazu Haneda Breakdown of academic impact, for papers by Wolfgang Patsch Breakdown of academic impact, for papers by Daisuke Koya Breakdown of academic impact, for papers by Barry J. Goldstein Breakdown of academic impact, for papers by Josef R. Patsch Breakdown of academic impact, for papers by Giorgio Sesti Breakdown of academic impact, for papers by Shun Ishibashi Breakdown of academic impact, for papers by Josephine M. Forbes Breakdown of academic impact, for papers by John D. Brunzell Breakdown of academic impact, for papers by Fredrik Karpe